All Topics

Discover the pathways to U.S. citizenship, from birth and naturalization to military service. Learn about eligibility requirements, the naturalization process, common application pitfalls, and how to prepare effectively for becoming an American citizen.

Harrow has launched BYOOVIZ (ranibizumab-nuna), the first FDA-approved ophthalmic biosimilar, following an exclusive commercialization agreement with Samsung Bioepis after Biogen's exit from the U.S. market. This marks the beginning of Harrow's partnership to commercialize Samsung Bioepis's ophthalmology biosimilar portfolio, which also includes OPUVIZ, a biosimilar referencing EYLEA.

The New Jersey Supreme Court has implemented sweeping changes to its appellate briefing procedures, introducing a consolidated merits briefing system that replaces the previous fragmented approach. These amendments establish new deadlines, page limits, and amicus participation rules that fundamentally reshape how appeals are presented to the state's highest court.